Shares of HIMS experienced a dramatic slump today following the unexpected termination of its agreement with pharmaceutical giant Novo Nordisk. Investors reacted negatively to the news, sending HIMS's stock price plummeting by nearly 10%. The reason for the dissolution of the partnership remains unclear, but industry analysts speculate that it coul